Kangji Medical Holdings Limited (FRA:50J)

Kangji Medical Holdings Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,047	1,009	926.02	786.37	690.26	511.49
Revenue Growth (YoY)	6.72%	8.92%	17.76%	13.92%	34.95%	1.59%
Cost of Revenue	219.87	210.96	184.82	151.12	127.34	80.02
Gross Profit	826.89	797.65	741.2	635.25	562.93	431.47
Selling, General & Admin	161.17	175.53	170.11	124.64	108.58	94.58
Research & Development	72.6	82.08	127.55	66.02	36	25.22
Operating Expenses	235.67	257.33	298.73	189.61	145.19	119.8
Operating Income	591.21	540.32	442.47	445.64	417.74	311.67
Interest Expense	-0.07	-0.64	-2.26	-1.88	-0.2	-0.04
Interest & Investment Income	50.73	92.13	91.89	70	51.59	17.14
Earnings From Equity Investments	-35.54	-21.86	-	-	-	-
Currency Exchange Gain (Loss)	5.62	-12.98	-3.1	-3.2	3.12	-25.04
Other Non Operating Income (Expenses)	-14.95	55.37	54.16	53.15	30.78	35.82
EBT Excluding Unusual Items	597.01	652.34	583.16	563.72	503.02	339.55
Gain (Loss) on Sale of Investments	10.46	5.24	5.56	-0.76	31.6	2.94
Gain (Loss) on Sale of Assets	28.51	27.25	0.05	0.19	-0.12	-0.1
Other Unusual Items	46	-	-	-	-	-32.31
Pretax Income	681.98	684.83	588.77	563.14	534.5	310.08
Income Tax Expense	120.63	113.56	136.48	101.97	77.71	50.93
Earnings From Continuing Operations	561.35	571.28	452.3	461.17	456.79	259.15
Minority Interest in Earnings	-	10.16	51.73	17.56	-	-8.85
Net Income	561.35	581.44	504.02	478.74	456.79	250.3
Net Income to Common	561.35	581.44	504.02	478.74	456.79	250.3
Net Income Growth	5.04%	15.36%	5.28%	4.80%	82.50%	21.24%
Shares Outstanding (Basic)	1,179	1,176	1,170	1,208	1,224	953
Shares Outstanding (Diluted)	1,179	1,176	1,172	1,208	1,232	964
Shares Change (YoY)	0.68%	0.29%	-2.95%	-1.95%	27.83%	-6.13%
EPS (Basic)	0.48	0.49	0.43	0.40	0.37	0.26
EPS (Diluted)	0.48	0.49	0.43	0.40	0.37	0.26
EPS Growth	4.33%	15.03%	8.48%	6.88%	42.78%	29.16%
Free Cash Flow	485.41	504.81	335.89	243.62	404.88	203.21
Free Cash Flow Per Share	0.41	0.43	0.29	0.20	0.33	0.21
Dividend Per Share	0.240	0.240	0.410	0.184	0.140	0.037
Dividend Growth	-41.46%	-41.46%	122.22%	31.44%	278.86%	-
Gross Margin	79.00%	79.08%	80.04%	80.78%	81.55%	84.36%
Operating Margin	56.48%	53.57%	47.78%	56.67%	60.52%	60.93%
Profit Margin	53.63%	57.65%	54.43%	60.88%	66.18%	48.94%
Free Cash Flow Margin	46.37%	50.05%	36.27%	30.98%	58.66%	39.73%
EBITDA	617.75	562.6	464.58	460.32	427.25	319.14
EBITDA Margin	59.02%	55.78%	50.17%	58.54%	61.90%	62.40%
D&A For EBITDA	26.54	22.28	22.11	14.68	9.52	7.47
EBIT	591.21	540.32	442.47	445.64	417.74	311.67
EBIT Margin	56.48%	53.57%	47.78%	56.67%	60.52%	60.93%
Effective Tax Rate	17.69%	16.58%	23.18%	18.11%	14.54%	16.42%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.